This section is intended for patients prescribed Alunbrig. If you are a member of the public click here. If you are a UK healthcare professional click here.

About Alunbrig  (brigatinib)

Alunbrig is a treatment for people with a specific type of lung cancer. It has been given to you because:

  • You have lung cancer with a certain type of abnormal gene called ALK (anaplastic lymphoma kinase), described as ALK-positive advanced non-small cell lung cancer, or ALK+ aNSCLC.

How does Alunbrig work?

Cancer grows and spreads by cells dividing. The abnormal ALK gene produces a protein known as a kinase that stimulates the growth of the cancer cells. Alunbrig blocks the action of this protein, thereby slowing down the growth and spread of the cancer.

Speak to your nurse or oncologist if you would like more information on how Alunbrig may work for you

Patient Alert Card thumbnail

Patient Alert Card

Carry this card with you at all times and take it with you to any medical appointments you may have. You should present it to any doctors or nurses treating you, even if they are not your usual treating oncologist or lung nurse.

Patient booklet thumbnail

My Patient Booklet

This guide contains information for people taking Alunbrig for the treatment of ALK-positive advanced non-small cell lung cancer (aNSCLC) after previous crizotinib treatment. It also contains the patient alert card.

Download booklet